Cytomed Therapeutics Ltd. (GDTC)
Market Closed
15 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
0. 87
+0.01
+1.1628%
$
10.53M Market Cap
- P/E Ratio
- Div Yield
9,500 Volume
-0.26 Eps
$ 0.86
Previous Close Want to track GDTC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cytomed Therapeutics Ltd. (GDTC) Statistics
Valuation metrics
Market Cap 10.53M
Enterprise value 12.48M
Trailing P/E (ttm) -2.48
Forward P/E -
PEG ratio 0.48
Price/Sales (ttm) 20.26
Price/Book (mrq) 2.72
Enterprise Value/Revenue 18.75
Enterprise Value/EBITDA -2.05
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 23.21K
Average volume (90 days) 75.84K
Price summary
52-Week low 0.68
52-Week high 3.68
Beta -
50-Day moving average 0.91
200-Day moving average 0.98
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -8.26%
Operating margin -8.53%
Operational effectiveness
Return on assets -0.78%
Return on equity -0.87%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.06
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.46
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.12
Total debt (mrq) -
Total Debt/Equity (mrq) 0.09
Current ratio (mrq) 2.64%
Book value per share (mrq) 0.45
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
